Literature DB >> 20973868

The effect of combined steroid and calcium channel blocker injection on human hypertrophic scars in animal model: a new strategy for the treatment of hypertrophic scars.

Jui-Yung Yang1, Chun-Yuan Huang.   

Abstract

BACKGROUND: Hypertrophic scars (HScs) are inelastic scars that can cause functional loss and disfigurement. Decorin regulates collagen fibrillogenesis, and its expression is lower in HScs than in normal skin and during wound healing.
OBJECTIVE: To evaluate the efficacy of combined verapamil and triamcinolone in treating HScs.
METHODS: Excised human HSc fragments from surgically treated burned patients were divided into three groups: A (normal saline), B (verapamil), and C (verapamil and triamcinolone). The specimens were bilaterally implanted in the back of nude mice, treated using intralesional injections, and observed for 4 weeks. We compared the fibroblast viability and proliferation, decorin staining, and scar weights to evaluate treatment efficacy.
RESULTS: Viability and proliferation of HSc fibroblasts from groups B and C were significantly lower at all time intervals after transplantation (p<.001). Treatment (Groups B and C) stimulated strong decorin staining by 4 weeks. Nonsignificant differences in changes in scar weight were observed between groups.
CONCLUSIONS: We present the first evidence of verapamil-augmented decorin expression spatially correlated with collagen bundles in HScs. Combination therapy can reduce the dosage of each drug but achieve equal or better efficacy than monotherapy, reducing the side effects of a single drug. The authors have indicated no significant interest with commercial supporters.
© 2010 by the American Society for Dermatologic Surgery, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20973868     DOI: 10.1111/j.1524-4725.2010.01759.x

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  7 in total

1.  Role of verapamil in preventing and treating hypertrophic scars and keloids.

Authors:  Ru Wang; Yu Mao; Zhenyu Zhang; Zhengyong Li; Junjie Chen; Ying Cen
Journal:  Int Wound J       Date:  2015-05-12       Impact factor: 3.315

Review 2.  Recent developments in the use of intralesional injections keloid treatment.

Authors:  Aurelia Trisliana Perdanasari; Davide Lazzeri; Weijie Su; Wenjing Xi; Zhang Zheng; Li Ke; Peiru Min; Shaoqing Feng; Yi Xin Zhang; Paolo Persichetti
Journal:  Arch Plast Surg       Date:  2014-11-03

3.  Effect of P144® (Anti-TGF-β) in an "In Vivo" Human Hypertrophic Scar Model in Nude Mice.

Authors:  Shan Shan Qiu; Javier Dotor; Bernardo Hontanilla
Journal:  PLoS One       Date:  2015-12-31       Impact factor: 3.240

Review 4.  Evidence-based therapy in hypertrophic scars: An update of a systematic review.

Authors:  Sebastian P Nischwitz; Katharina Rauch; Hanna Luze; Elisabeth Hofmann; Alexander Draschl; Petra Kotzbeck; Lars-Peter Kamolz
Journal:  Wound Repair Regen       Date:  2020-06-15       Impact factor: 3.617

5.  Treatment of Keloids: A Meta-analysis of Intralesional Triamcinolone, Verapamil, and Their Combination.

Authors:  Kara Klomparens; Richard Simman
Journal:  Plast Reconstr Surg Glob Open       Date:  2022-01-27

Review 6.  A Systematic Review Comparing Animal and Human Scarring Models.

Authors:  Riyam Mistry; Mark Veres; Fadi Issa
Journal:  Front Surg       Date:  2022-04-22

7.  A new treatment of hypertrophic and keloid scars with combined triamcinolone and verapamil: a retrospective study.

Authors:  S B Kant; E van den Kerckhove; C Colla; S Tuinder; R R W J van der Hulst; A A Piatkowski de Grzymala
Journal:  Eur J Plast Surg       Date:  2017-06-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.